HPV vaccination in women aged 24-45 years.
Solomon
Diane
D
Castle
Phil
P
Hildesheim
Allan
A
Katki
Hormuzd A
HA
Schiffman
Mark
M
Wacholder
Sholom
S
D000328:Adult; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D008875:Middle Aged; D053918:Papillomavirus Vaccines / Q000276:immunology*; D011634:Public Health; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D014611:Vaccination; D002578:Uterine Cervical Dysplasia / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology
D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines